Luis Lara‐Mejía

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Diego de Miguel‐Pérez, Alessandro Russo, Óscar Arrieta et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 97 citations · Full text

Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer

Ana González-Ling, Oscar Vazquez, Marcos Espinoza Bello et al. · Palliative & Supportive Care · 2022 · 54 citations

Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study

M. Blake-Cerda, Francisco Javier Lozano Ruíz, Federico Maldonado‐Magos et al. · Lung Cancer · 2020 · 29 citations

Radiation Therapy, Medicine, Prospective Phase 2 +8

Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC

Luis Lara‐Mejía, Andrés F. Cardona, Luís Más et al. · Journal of Thoracic Oncology · 2023 · 23 citations · Full text

Concurrent Genomic Alterations, Oncology, Genetic Disorder +9

Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior

Rubén Rodríguez‐Bautista, C H S Caro-Sánchez, Paula Cabrera‐Galeana et al. · Cancers · 2021 · 17 citations · Full text